Huzair, Farah (Author)
Sturdy, Steve (Author)
The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we show how the early development of the hepatitis B vaccines was shaped by a political and economic context that newly favoured commercialisation of academic research, including the appropriation and management of intellectual property; we elucidate the contingent interests and motivations that led new biotechnology companies and established pharmaceutical businesses to invest in developing recombinant vaccines specifically against hepatitis B; and we show how these and other factors combined to make those vaccines an unexpected commercial success. Broadening the scope of our analysis to include not just North America and Europe but also low- and middle-income countries, we show how the development of the hepatitis B vaccines facilitated the emergence of a two-tier innovation system structured by tensions between the demands for commercial profitability on the one hand, and the expectation of public health benefit for low- and middle-income countries on the other.
...More
Article
Yi, Doogab;
(2011)
Who Owns What? Private Ownership and the Public Interest in Recombinant DNA Technology in the 1970s
(/isis/citation/CBB001220006/)
Article
Doogab Yi;
(2022)
Correcting Life through the Marketplace? Genome Editing and the Commercialization of Academic Research in South Korea
(/isis/citation/CBB498505166/)
Article
Miyoung Shin;
(2020)
Finding the key to solving problems in the hepatitis kingdom: A Study on the Development of Hepatitis B Vaccine by Kim Chung Young in the 1960-70s
(/isis/citation/CBB571637573/)
Article
Baldini, Nicola;
Fini, Riccardo;
Grimaldi, Rosa;
Sobrero, Maurizio;
(2014)
Organisational Change and the Institutionalisation of University Patenting Activity in Italy
(/isis/citation/CBB001420874/)
Book
Charles Lawson;
Berris Charnley;
(2015)
Intellectual Property and Genetically Modified Organisms: A Convergence in Laws
(/isis/citation/CBB742382287/)
Article
Eda Kranakis;
(2019)
A Tale of Two Inventions: Monsanto, Biotechnology, and the Geography of Postmodern Science
(/isis/citation/CBB875215202/)
Article
Greene, Jeremy A.;
(2013)
The Materiality of the Brand: Form, Function, and the Pharmaceutical Trademark
(/isis/citation/CBB001320757/)
Book
William W. Foege;
Jimmy Carter;
(2018)
The Task Force for Child Survival: Secrets of Successful Coalitions
(/isis/citation/CBB819770729/)
Book
Anna Kirkland;
(2016)
Vaccine Court: The Law and Politics of Injury
(/isis/citation/CBB053136475/)
Article
Baptiste Baylac-Paouly;
(2019)
Vaccine development as a ‘doable problem’: The case of the meningococcal A vaccines 1962–1969
(/isis/citation/CBB049448868/)
Article
Day, Alison;
(2009)
“An American Tragedy”. The Cutter Incident and Its Implications for the Salk Polio Vaccine in New Zealand, 1955--1960
(/isis/citation/CBB001232089/)
Article
Lindner, Ulrike;
Blume, Stuart S.;
(2006)
Vaccine Innovation and Adoption: Polio Vaccines in the UK, the Netherlands and West Germany, 1955--1965
(/isis/citation/CBB000773962/)
Thesis
Pacino, Nicole Lohman;
(2013)
Prescription for a Nation: Public Health in Post-Revolutionary Bolivia, 1952--1964
(/isis/citation/CBB001567448/)
Article
Porras, María Isabel;
Báguena, María José;
Ballester, Rosa;
de las Heras, Jaime;
(2012)
La Asociación Europea contra la Poliomielitis y los programas europeos de vacunación
(/isis/citation/CBB001211095/)
Book
Largent, Mark A.;
(2012)
Vaccine: The Debate in Modern America
(/isis/citation/CBB001213531/)
Book
O'Doherty, Kieran;
Einsiedel, Edna F;
(2013)
Public Engagement and Emerging Technologies
(/isis/citation/CBB001420078/)
Book
Blumberg, Baruch S.;
(2002)
Hepatitis B: The Hunt for a Killer Virus
(/isis/citation/CBB000201781/)
Article
Rodríguez Sánchez, J. A.;
Seco Calvo, J.;
(2009)
Las campañas de vacunación contra la poliomielitis en España en 1963
(/isis/citation/CBB000931888/)
Article
Gaëtan Thomas;
(2020)
Keeping Vaccination Simple: Building French Immunization Schedules, 1959–1999
(/isis/citation/CBB403225677/)
Article
Anne Hagen Berg;
Stuart S. Blume;
(2020)
Reasonable Grounds? The Delayed Introduction of MMR Vaccine in Denmark and the Netherlands, 1977–87
(/isis/citation/CBB482754558/)
Be the first to comment!